Literature DB >> 15680545

Heterogeneous cellular environments modulate one-hit neuronal death kinetics.

Geoff Clarke1, Charles J Lumsden.   

Abstract

We recently demonstrated that cell loss kinetics in diverse forms of neurodegeneration (ND) suggests a universal death switch mechanism in which each cell is at a constant risk to initiate apoptosis. We proposed that mutant and injured neurons exist in a viable state typified by an increased risk of initiating death processes [Clarke, Collins, Leavitt, Andrews, Hayden, Lumsden, McInnes, A one-hit model of cell death in inherited neuronal degenerations, Nature 406 (2000) 195-199]. To date, however, measurements of cell death risk have been available only as averages across the affected cell population. Here we develop and apply a method of death kinetic analysis in which the risk factors vary across the neuronal population, as for example due to regional heterogeneities in the cellular microenvironment. We find that most cases of ND for which cell loss data has been obtained are better explained by death risks that vary from cell to cell, compared to death risk that is constant across the neuronal population. Strikingly, a common form of the frequency distribution defining the death risk heterogeneity is shared across most of these cases. This first characterization of the kinetic heterogeneity in one-hit neuronal death, therefore, suggests that the wide variety of ND now known may share mechanisms through which regional differences in the cellular microenvironment modulate the kinetics of cell loss.

Entities:  

Mesh:

Year:  2005        PMID: 15680545     DOI: 10.1016/j.brainresbull.2004.11.009

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  6 in total

1.  Shapes of the trajectories of 5 major biomarkers of Alzheimer disease.

Authors:  Clifford R Jack; Prashanthi Vemuri; Heather J Wiste; Stephen D Weigand; Timothy G Lesnick; Val Lowe; Kejal Kantarci; Matt A Bernstein; Matthew L Senjem; Jeffrey L Gunter; Bradley F Boeve; John Q Trojanowski; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; David S Knopman
Journal:  Arch Neurol       Date:  2012-07

2.  BDNF may play a differential role in the protective effect of the mGluR2/3 agonist LY379268 on striatal projection neurons in R6/2 Huntington's disease mice.

Authors:  A Reiner; H B Wang; N Del Mar; K Sakata; W Yoo; Y P Deng
Journal:  Brain Res       Date:  2012-07-20       Impact factor: 3.252

Review 3.  Pathogenesis of cerebral palsy through the prism of immune regulation of nervous tissue homeostasis: literature review.

Authors:  Natalya Lisovska; Zholtay Daribayev; Yevgeny Lisovskyy; Kenzhe Kussainova; Lana Austin; Sholpan Bulekbayeva
Journal:  Childs Nerv Syst       Date:  2016-09-14       Impact factor: 1.475

4.  Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis.

Authors:  Jason Miller; Montserrat Arrasate; Benjamin A Shaby; Siddhartha Mitra; Eliezer Masliah; Steven Finkbeiner
Journal:  J Neurosci       Date:  2010-08-04       Impact factor: 6.167

5.  ABCA4 disease progression and a proposed strategy for gene therapy.

Authors:  Artur V Cideciyan; Malgorzata Swider; Tomas S Aleman; Yaroslav Tsybovsky; Sharon B Schwartz; Elizabeth A M Windsor; Alejandro J Roman; Alexander Sumaroka; Janet D Steinberg; Samuel G Jacobson; Edwin M Stone; Krzysztof Palczewski
Journal:  Hum Mol Genet       Date:  2008-12-12       Impact factor: 6.150

6.  Rod function deficit in retained photoreceptors of patients with class B Rhodopsin mutations.

Authors:  Artur V Cideciyan; Samuel G Jacobson; Alejandro J Roman; Alexander Sumaroka; Vivian Wu; Jason Charng; Brianna Lisi; Malgorzata Swider; Gustavo D Aguirre; William A Beltran
Journal:  Sci Rep       Date:  2020-07-28       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.